regadenoson
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
20 FDA-registered drug labelers
Accord Healthcare Inc.
Almaject, Inc.
Apicore Pharmaceuticals Private Limited
Apotex Corp.
Astellas Pharma US, Inc.
Baxter Healthcare Corporation
Eugia US LLC
Farmak, a,s
Gland Pharma Limited
HF Acquisition Co LLC, DBA HealthFirst
Indies Pharma Jamaica Limited
Kanchan Healthcare Inc
Marlex Pharmaceuticals, Inc.
Meitheal Pharmaceuticals Inc.
MSN Life Sciences Private Limited
Mylan Institutional LLC
ScinoPharm Taiwan Ltd.
Sionc Pharmaceutical Private Limited
SUN PHARMACEUTICAL INDUSTRIES, INC.
USV Private Limited
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •regadenoson
- •Lexiscan
- •Lexiscan(R) (Regadenoson)
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS313348-27-5
PubChem CID219024
DTXSIDDTXSID4057712
FormulaC15H18N8O5
Mol. Weight390.35 g/mol
SMILESCNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N
Data Sources
2190242026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/regadenoson/cids/JSON
Archive: data/sources/pubchem_name/regadenoson.json
CAS 313348-27-52026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json